BeOne Medicines AG (ONC) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript

Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 9:30 AM ESTCompany ParticipantsAaron ...

Aptose Reports Third Quarter 2025 Results

Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug ...
Daily Mail

Do trial separations work?

The sad news that Zoe Ball and Norman Cook's marriage isn't working was accompanied by the admission that their tactic for sorting out their differences will be to separate for a while. Trial ...

Aptose Biosciences, Inc.: Aptose Reports Third Quarter 2025 Results

Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at Increased Dose LevelsPatients are Now Be ...